Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.

Szczegóły
Abstrakt

Tytuł:: Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Autorzy:: Wu SG; Department of Radiation Oncology, Cancer Hospital, the First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland).
Li FY; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China (mainland).
Lei J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland).
Hua L; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland).
He ZY; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland).
Zhou J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland).
Źródło:: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Feb 02; Vol. 26, pp. e920531. Date of Electronic Publication: 2020 Feb 02.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 2014- : Smithtown, NY : International Scientific Information, Inc.
Original Publication: Warsaw, Poland : Medical Science International
MeSH Terms:: Databases as Topic*
SEER Program*
Carcinoma, Ovarian Epithelial/*epidemiology
Carcinoma, Ovarian Epithelial/*pathology
Ovarian Neoplasms/*epidemiology
Ovarian Neoplasms/*pathology
Carcinoma, Ovarian Epithelial/mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Ovarian Neoplasms/mortality ; Prognosis ; Proportional Hazards Models ; Time Factors
References:: Clin Cancer Res. 2019 Jul 1;25(13):3962-3973. (PMID: 30967419)
J Clin Oncol. 2002 Mar 1;20(5):1248-59. (PMID: 11870167)
Int J Gynecol Cancer. 2019 May 15;:. (PMID: 31097512)
J Clin Oncol. 2007 Aug 20;25(24):3621-7. (PMID: 17704411)
Cancer. 2008 May 15;112(10):2202-10. (PMID: 18348296)
J Natl Cancer Inst. 2000 May 3;92(9):699-708. (PMID: 10793106)
Nat Rev Cancer. 2009 Jun;9(6):415-28. (PMID: 19461667)
Lancet. 2018 Mar 17;391(10125):1023-1075. (PMID: 29395269)
Gynecol Oncol. 2016 Mar;140(3):474-80. (PMID: 26743531)
Gynecol Oncol. 2017 Nov;147(2):243-249. (PMID: 28807367)
BMC Cancer. 2018 May 29;18(1):601. (PMID: 29843633)
J Clin Oncol. 2003 Sep 1;21(17):3194-200. (PMID: 12860964)
Gynecol Oncol. 2015 Jan;136(1):1-2. (PMID: 25554011)
Eur J Cancer. 2013 Oct;49(15):3191-201. (PMID: 23850170)
Front Oncol. 2018 Dec 04;8:577. (PMID: 30564556)
J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9. (PMID: 12953086)
Obstet Gynecol. 2015 Sep;126(3):491-7. (PMID: 26244529)
J Natl Cancer Inst. 2003 Jan 15;95(2):113-25. (PMID: 12529344)
Int J Gynecol Cancer. 2010 Aug;20(6):945-52. (PMID: 20683400)
Obstet Gynecol. 2015 Jun;125(6):1345-52. (PMID: 26000505)
Eur J Cancer. 2016 May;59:22-33. (PMID: 26998845)
J Clin Oncol. 2016 Aug 20;34(24):2881-7. (PMID: 27400948)
CA Cancer J Clin. 2018 Jul;68(4):284-296. (PMID: 29809280)
BMJ Open. 2016 Apr 21;6(4):e010123. (PMID: 27103625)
J Clin Oncol. 2015 Mar 10;33(8):937-43. (PMID: 25667285)
Lancet Oncol. 2019 Jun;20(6):862-876. (PMID: 31076365)
Front Oncol. 2019 Aug 06;9:639. (PMID: 31448220)
PLoS One. 2018 Mar 26;13(3):e0194993. (PMID: 29579127)
Lancet. 2001 Jan 20;357(9251):176-82. (PMID: 11213094)
Entry Date(s):: Date Created: 20200203 Date Completed: 20201124 Latest Revision: 20201124
Update Code:: 20240105
PubMed Central ID:: PMC7011572
DOI:: 10.12659/MSM.920531
PMID:: 32008036
: Czasopismo naukowe

BACKGROUND The prognosis of epithelial ovarian cancer (EOC) remains poor. Cause-specific survival (CSS) is an overall survival measure of cancer survival that excludes other causes of death. This retrospective population study used the Surveillance, Epidemiology, and End Results (SEER) database to evaluate prognostic factors associated with one-year CSS in women with stage III-IV EOC between 2004-2014. MATERIAL AND METHODS Data from the SEER program included a cohort of patients with stage III-IV EOC between 2004-2014. Binomial logistic regression analysis, Kaplan-Meier survival curves, and multivariate Cox proportional hazards models were used for analysis of patient outcome, including the one-year CSS. RESULTS There were 14,798 patients with stage III-IV EOC identified from SEER between 2004-2014, including 13,134 (88.8%), 892 (6.0%), 448 (3.0%), and 324 (2.2%) patients with serous, endometrioid, clear cell, and mucinous ovarian cancer, respectively. The overall one-year CSS was 91.2%. One-year CSS was 92.5%, 92.2%, 74.0%, and 62.5% in patients with serous, endometrioid, clear cell, and mucinous ovarian cancer, respectively (P<0.001). Histological tumor type was an independent prognostic factor of one-year CSS. Patients with mucinous EOC (HR, 8.807; 95% CI, 6.563-9.965; P<0.001) and clear cell EOC (HR, 4.581; 95% CI, 3.774-5.560; P<0.001) had a significantly lower one-year CSS compared with patients with endometrioid and serous EOC who had comparable one-year CSS (HR, 1.247; 95% CI, 0.978-1.590; P=0.075). CONCLUSIONS A retrospective population study of the SEER database between 2004-2014 identified that histological tumor type was associated with one-year CSS in women with stage III-IV EOC.

Informacja